Vistry Group reported a significant first-half pre-tax loss of £661.3 million, driven by a £475 million goodwill impairment and increased building safety costs. Revenue fell to £1.42 billion, and operational performance weakened with fewer home completions. In response, the company is undertaking a strategic review to simplify operations, reduce debt, and focus on partner-backed housing, aiming for 12,000 annual completions and £50 million in overhead savings. Vistry also lowered its 2026 profit outlook and expects a neutral year-end cash position, highlighting a shift to a smaller, more disciplined business model amid challenging market conditions.
Vistry Group reported a substantial first-half pre-tax loss of £661.3 million amid strategic shifts. For readers following the Real Estate sector, here is Pluang's market snapshot as of Sep 25, 2026 01:01 WIB: among 26 priced US Real Estate stocks, 8 rose and 18 fell. Notable prices include ARE at USD 50.76 with a 1-day change of -2.12%, VICI at USD 23.29 with a 1-day change of -1.79% and a Pluang order activity of 59% Sell / 41% Buy, and AGNC at USD 9.74 with a 1-day change of -1.66% and a Pluang order activity of 5% Sell / 95% Buy.
Costco reported a strong Q4 earnings per share (EPS) of $6.75, surpassing analyst expectations of $6.54, helped by tariff refunds. Although quarterly revenue of $93.87 billion slightly missed the $94.97 billion forecast, net sales rose 11.2% year-ove...
Vail Resorts is set to report its Q3 2026 earnings on September 28, with analysts forecasting a loss per share around -$5.30 and revenue near $271 million, indicating flat performance year-over-year. The company’s financial health shows a high Debt-t...
Western Union faces multiple analyst downgrades with price targets cut to as low as $6.00, reflecting concerns over its profitability and competitive pressures from fintech rivals. The stock has fallen over 15% in the past month, trading near $6.00, ...
Citigroup lowered ACADIA Pharmaceuticals' price target from $40 to $33 after its Alzheimer's drug remlifanserin missed the primary goal in a mid-stage trial, causing a 10.5% stock drop. Despite this, Citigroup kept a "Buy" rating, citing promising se...
Kroger is leveraging decades of retail data to implement an AI strategy aimed at enhancing customer experience and operational efficiency. The company reported earnings per share of $1.09, beating estimates, but revenue slightly missed projections at...
